AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV
Clinical trial NCT00126880 · COMPLETED
Trial details
- NCT number
- NCT00126880
- Sponsor
- Avexa
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2008-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.